References
- De Gaetano Donati K, Tumbarello M, Tacconelli E, Betagnolio S, Rabagliati R, Scoppettuolo G, et al. Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV-infected subjects. J Chemother 2003; 16: 60–5
- Feikin D, Feldman C, Schuchat A, Janoff E. Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect Dis 2004; 4: 445–55
- Boumis E, Petrosillo N, Girardi E, de Carli G, Armignacco O, Visca P, et al. Changing patterns in the aetiology of HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis 2001; 20: 71–3
- Viale P, Scudeller L, Petrosillo N, Girardi E, Cadeo B, Signorini L, et al. Clinical stability in human immunodeficiency virus-infected patients with community-acquired pneumonia. Clin Infect Dis 2004; 38: 271–9
- Feldman C. Pneumonia associated with HIV infection. Curr Opin Infect 2005; 18: 165–70
- Janoff EN, Breiman RF, Daley CL, Hopewell PC. Pneumococcal disease during HIV infection. Epidemiological, clinical and immunological perspectives. Ann Intern Med 1992; 117: 314–24
- Garcia-Leoni ME, Moreno S, Rodeñó P, Cercenado E, Vicente T, Bouza E. Pneumococcal pneumonia in adult hospitalized patients infected with the human immunodeficiency virus. Arch Intern Med 1992; 152: 1808–12
- Frankel RE, Virata M, Hardalo C, Altice FL, Friedland G. Invasive pneumococcal disease: clinical features, serotypes and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection. Clin Infect Dis 1996; 23: 577–84
- Sopena N, Sabriá M, Pedro-Botet ML, Manterola JM, Matas L, Dominguez J, et al. Prospective study of community-acquired pneumonia of bacterial aetiology in adults. Eur J Clin Microbiol Infect Dis 1999; 18: 852–8
- Vergis EN, Akbas E, Yu VL. Legionella as a cause of severe pneumonia. Sem Respir Crit Care Med 2000; 21: 295–304
- Marston BJ, Lipman HB, Breiman RF. Surveillance for Legionnaires’ disease risk factors for morbidity and mortality. Arch Intern Med 1994; 154: 2417–22
- Casau NC. Low prevalence of Legionnaires’ disease in HIV-infected patients. AIDS Read 2004; 14: 269
- Bangsborg JM, Jensen BN, Friis-Moller A, Bruun B. Legionellosis in patients with HIV infection. Infection 1990; 18: 342–6
- Blatt SP, Dolan MJ, Hendrix CW, Melcher GP. Legionnaires’ disease in human immunodeficiency virus-infected patients: 8 cases and review. Clin Infect Dis 1994; 18: 227–32
- Harris A, Lally M, Albrecht M. Legionella bozemanii pneumonia in 3 patients with AIDS. Clin Infect Dis 1998; 27: 97–9
- Sene D, Bossi P, Thomas L, Ghosn J, Zeller V, Caumes E, et al. Legionellosis chez les patients infectés par le VIH-1. Four observations. Presse Med 2002; 31: 356–8
- Dumoff K, McGovern PC, Edelstein PH, Nachamkin I. Legionella maccachernii pneumonia in a patient with HIV infection. Diag Microbiol Infect Dis 2004; 50: 141–5
- Franzin L, Dal Coute I, Cabodi D, Sinicco A. Culture proven Legionella pneumophila pneumonia in HIV-infected patients: case report and review. J Infect 2002; 45: 199–201
- Pedro-Botet ML, Sabriá M, Sopena N, García-Núñez M, Reynaga E, et al. Legionnaires’ disease and HIV infection. Chest 2003; 124: 543–7
- Jordano Q, Falcó V, Almirante B, Planes AM, del Valle O, Ribera E, et al. Invasive pneumococcal disease in patients infected with HIV: still a treat in the era of highly active antiretroviral therapy. Clin Infect Dis 2004; 38: 1623–8
- Dworkin MS, Ward JW, Hanson DL, Jones JL, Kaplan JE and the Adult and Adolescent Spectrum of HIV Project. Pneumococcal disease among human immunodeficiency virus-infected persons. Incidence, risk factors and impact vaccination. Clin Infect Dis 2001;32:794–800.
- Hirschtick RE, Glassroth J, Jordan MC, Wilcosky TC, Wallace JM, Kvale PA, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 1995; 333: 845–51
- Elssner A, Carter JE, Yunger TM, Wewers MD. HIV-1 infection does not impair human alveolar macrophage phagocytic function unless combined with cigarette smoking. Chest 2004; 125: 1071–6
- Martin WT, Boyle CA, Bernard K, Williams KE, Conly JM. Pneumonia with pleural effusion due to Legionella pneumophila serogroup lansing 3. Diagnostic Microbiology and Infectious Diseases 1995; 21: 101–3
- Sopena N, Sabria-Leal M, Pedro-Botet ML, Padilla E, Domínguez J, Morera J, et al. Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias. Chest 1998; 113: 1195–1200
- Granados A, Podzamczer D, Gudiol F, Manresa F. Pneumonia due to L. pneumophila and pneumococcal pneumonia: similarities and differences on presentation. Eur Respir J 1989; 2: 130–4
- Helms CM, Viner JR, Sturm RH, Renner ED, Johnson W. Comparative features of pneumococcal, mycoplasma and Legionella pneumonia. Ann Intern Med 1979; 90: 543–7
- Falcó V, Fernandez de Sevilla T, Alegre J, Ferrer A, Martínez Vazquez JM. Legionella pneumophila: a cause of severe community-acquired pneumonias. Chest 1991; 100: 1007–11
- Miller AC. Early clinical differentiation between Legionnaires’ disease and other sporadic pneumonias. Ann Intern Med 1979; 90: 526–8
- Olaechea PM, Quintana MM, Gallardo MS, Insausti J, Maravi E, Alvarez B. A predictive model for the treatment approach to community-acquired pneumonia in patients needing ICU admission. Intensive Care Med 1996; 22: 1294–300
- Cunha BA. Clinical features of Legionnaires’ disease. Semin Respir Infect 1998; 13: 116–27
- Gupta SK, Imperiale TF, Sarosi GA. Evaluation of the Winthrop-University hospital criteria to identify Legionella pneumonia. Chest 2001; 120: 1064–71
- Mulazimoglu L, Yu VL. Can Legionniares’ disease be diagnosed by clinical criteria? A critical review. Chest 2001; 120: 1049–53